Heart failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants were aged between 40 and 90 years16. 2. 24-hour ambulatory electrocardiogram (Holter) monitoring was performed upon admission14. 3. Comprehensive laboratory tests were conducted, including cardiac ultrasonography, pro-B-type natriuretic peptide (proBNP), complete blood count, hepatic and renal function panels, blood glucose, electrolyte levels, and lipid profile
Exclusion criteria
Exclusion criteria: 1. Patients with non-sinus rhythm (e.g., atrial flutter, atrial fibrillation, severe atrioventricular block, or pacemaker implantation); 2. Presence of other diseases affecting autonomic nervous function, such as hyperthyroidism, psychiatric disorders, or neurological disorders; 3. Comorbid severe valvular heart disease; 4. Severe infection; 5. Severe renal insufficiency (eGFR <30 mL/min/1.73m²); 6. Rheumatic and autoimmune diseases; 7. Life-limiting diseases other than coronary artery disease; 8. Psychologically or legally incapacitated; 9. History of malignant tumors; 10. Inability to cooperate with the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trypase; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Rate Variability; | — |
Countries
China
Contacts
Renmin Hospital of Wuhan University